Proton therapy
Also known as: proton beam therapy, proton radiotherapy, proton beam radiation therapy
Proton therapy is a type of radiation treatment that uses proton beams to deliver most of the dose at a chosen depth in tissue.
What it is
Proton therapy is a type of radiation treatment that uses proton beams to deliver most of the dose at a chosen depth in tissue. The key physical feature is the Bragg peak, where protons deposit most of their energy near the end of their path and then stop, which can reduce radiation dose beyond the tumour compared with standard X-ray, or photon, radiotherapy.
Like other forms of radiotherapy, proton therapy damages DNA in cancer cells so they stop dividing or die. Its main advantage is not that it is automatically stronger, but that it can sometimes shape dose more precisely around tumours that sit close to sensitive organs such as the brain, spinal cord, eye, heart, or bowel. This is why proton therapy is often discussed for selected childhood cancers, skull-base tumours, some head and neck cancers, eye tumours, and certain re-irradiation cases.
Proton therapy is a treatment modality, not a separate cancer medicine. It is usually given in multiple sessions, called fractions, after detailed planning CT and often MRI. In India, access is still limited to a small number of specialised centres, so travel, cost, and case selection matter.
| Term | What it means |
|---|---|
| Proton therapy | External-beam radiation using positively charged particles |
| Photon therapy | Standard external-beam radiation using X-rays |
| Bragg peak | Point where protons release most of their energy before stopping |
| Fraction | One treatment session |
How it works
In photon radiotherapy, X-rays enter the body, pass through the tumour, and continue beyond it, so normal tissues in front of and behind the target receive some dose. In proton therapy, the beam can be tuned to stop at a specific depth. That allows radiation oncologists and medical physicists to reduce the "exit dose" to tissues beyond the target.
Modern proton treatment is usually delivered in one of two broad ways:
- Passive scattering: older technique that spreads and shapes the proton beam with hardware.
- Pencil beam scanning: newer technique that paints the dose spot by spot and can support intensity-modulated proton therapy.
This physical advantage does not guarantee better cancer control in every disease. The expected benefit depends on anatomy, tumour motion, nearby organs, prior radiation, and whether the lower dose to normal tissue is likely to translate into fewer side effects or safer dose escalation.
Treatment planning is complex. Teams use imaging, immobilisation masks or molds, and computer planning to compare proton plans with photon plans. For tumours that move with breathing, such as some lung or liver cancers, motion management is especially important because proton range can be affected by tissue density changes.
Evidence and uses
The strongest rationale for proton therapy is dose reduction to normal tissues, especially when tumours are close to critical structures or when long-term side effects are a major concern. This is particularly relevant in children, because reducing unnecessary radiation to developing tissues may lower risks of growth problems, hormonal effects, neurocognitive effects, hearing loss, and possibly later second cancers.
Common situations where proton therapy may be considered include:
- Paediatric cancers
- Skull-base and certain brain tumours
- Ocular tumours such as uveal melanoma
- Selected head and neck cancers
- Some spinal or paraspinal tumours
- Certain lymphomas where heart or breast dose matters
- Re-irradiation, when an area has already received radiation
- Selected prostate, liver, lung, pancreatic, breast, or oesophageal cancers in experienced centres
Evidence is not uniform across all cancers. Reviews note that proton therapy often improves dose distributions and may reduce some acute and late toxicities, but high-quality randomised comparisons with photon therapy remain limited for many indications. For prostate cancer, for example, available studies suggest proton therapy is feasible and effective, but it has not clearly shown superior survival over modern photon techniques in all patients. In several diseases, the question is less whether protons can treat the cancer and more whether the extra cost and limited availability produce meaningful clinical benefit.
A practical way to think about it is:
| Situation | Why proton therapy may help |
|---|---|
| Tumour near optic nerves, brainstem, spinal cord | Less dose to critical organs |
| Child or young adult | Lower integral dose to normal tissues |
| Prior radiation already given | May reduce overlap with previously treated tissues |
| Large moving tumour in chest/abdomen | Benefit may be harder to realise without advanced motion control |
In India, proton therapy may be discussed at tertiary cancer centres for selected patients, but many people still receive excellent care with IMRT, VMAT, stereotactic radiotherapy, or other advanced photon techniques. Proton therapy is not automatically the best option just because it is newer.
When to see a clinician
Ask a radiation oncologist about proton therapy if you or your child has a tumour close to important organs, has already had radiation before, or has been told that standard radiation may carry a high risk of long-term side effects. It is also reasonable to ask for a proton opinion if the cancer is in the brain, skull base, eye, head and neck region, spine, or in a child.
Useful questions include:
- Would a proton plan lower dose to important normal tissues compared with IMRT or other photon therapy?
- Is there evidence of fewer side effects for my specific cancer type?
- Will cancer control be the same, better, or uncertain?
- How many fractions are planned, and what side effects are expected?
- Is treatment available locally in India, and what are the travel and cost implications?
A second opinion can be helpful because the value of proton therapy is highly case-specific. Many centres decide based on comparative treatment planning rather than diagnosis alone.
Limitations and open questions
Proton therapy has clear physical advantages, but clinical advantages vary by disease. Evidence in humans is strong for some selected scenarios and still limited or evolving for others. Fewer side effects are plausible and often reported, yet not every patient will see a meaningful difference compared with high-quality modern photon radiotherapy.
There are also technical limits. Proton dose can be sensitive to patient setup, anatomy changes during treatment, and organ motion. This matters in tumours affected by breathing or weight loss during a treatment course. Access is another major limitation because proton centres are expensive to build and are not widely available.
Cost-effectiveness remains debated. For some paediatric and anatomically complex tumours, many experts consider the trade-off favorable. For more common adult cancers, the balance may depend on local expertise, insurance coverage, and whether planning shows a real reduction in dose to organs at risk.
The main open question is not whether proton therapy works, because it does, but which patients benefit enough to justify choosing it over advanced photon therapy. Ongoing comparative studies should clarify where proton therapy most improves toxicity, quality of life, and long-term outcomes.
FAQs
Is proton therapy better than regular radiation therapy?
Not always. Proton therapy can reduce radiation dose to normal tissues because protons stop at a chosen depth, unlike X-rays that continue beyond the target. That can matter a lot for tumours near the brain, spinal cord, eye, heart, or in children, but for some cancers modern photon techniques may work just as well.
Which cancers are most likely to be treated with proton therapy?
It is often considered for paediatric cancers, skull-base and some brain tumours, eye tumours, selected head and neck cancers, some spinal tumours, and re-irradiation cases. It may also be used for prostate, liver, lung, breast, oesophageal, or pancreatic cancers in selected patients. The final decision usually depends on whether a proton plan clearly lowers dose to nearby organs.
Does proton therapy have fewer side effects?
It can, but the benefit depends on the cancer site and treatment plan. Because proton beams can reduce dose beyond the tumour, they may lower some short-term and long-term side effects, especially when critical organs are close by. However, side effects still happen, and studies have not shown a major advantage for every cancer type.
Is proton therapy available in India?
Yes, but it is available only at a limited number of specialised centres. That means some patients may need to travel, arrange temporary accommodation, and compare costs with advanced photon radiotherapy such as IMRT or VMAT. A radiation oncologist can help decide whether the expected benefit is large enough to justify referral.
What should I ask before choosing proton therapy?
Ask whether your proton plan is actually better than the best photon plan for your case, not just whether proton therapy is available. Important details include the expected reduction in dose to organs at risk, the number of fractions, likely side effects, prior radiation history, and total cost. If the evidence for your cancer type is uncertain, a second opinion from a radiation oncologist with proton experience is reasonable.